Castle Biosciences, Inc.【CSTL】 業績推移・財務諸表

機能の使い方
(単位:%) 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 10,738 14,774 17,635 17,418 12,715 15,217 17,299 22,813 22,758 23,475 25,039 26,852 34,838 37,011 38,338 42,037 50,138 61,493 66,120 72,974 87,002 85,782 86,311 87,988 86,188 83,043 87,010
売上成長率(%) - - - - 30.5 20.6 -0.9 -3.2 0.8
売上原価 1,992 1,708 2,010 2,391 2,146 2,475 2,673 3,028 3,697 4,500 - 5,944 7,686 8,859 9,520 10,182 11,058 11,319 12,423 13,894 14,519 15,609 16,183 16,383 17,626 18,704 18,315
売上総利益 8,745 13,066 15,624 15,027 10,569 12,742 14,626 19,785 - - - - - - - - - - - - - - - - - - -
売上総利益率(%) - - - - - - - - - - - - - - - - - - -
研究開発費 1,317 1,514 3,158 2,913 2,704 3,058 4,581 5,908 6,793 7,500 9,445 10,761 11,926 10,907 11,309 14,393 13,308 12,923 12,994 13,809 14,136 12,323 11,773 12,588 12,787 12,960 13,515
販売管理費 6,820 7,121 9,852 11,078 10,392 11,703 14,959 18,161 20,822 22,595 25,160 30,453 37,498 36,626 38,426 46,762 44,681 44,619 44,090 48,495 51,088 50,499 49,965 58,620 58,065 55,907 56,731
営業費用 8,138 8,636 13,011 13,991 - - - 24,069 - - - - - - - - - - - - - - - - - - -
営業利益 607 4,429 2,612 1,036 -645 -3,901 -3,032 -4,284 -8,810 -11,814 -15,171 -24,516 -3,971 -21,536 -22,832 -31,522 -21,157 -9,640 -5,658 -5,471 5,012 5,079 4,050 -27,928 -4,251 -6,804 -3,827
営業利益率 (%) 4.7 -31.7 -4.9 -8.2 -4.4
経常(税引前)利益 -1,270 5,849 2,126 570 -1,376 -4,589 -4,805 -4,280 -8,786 -11,791 -15,155 -24,489 -3,605 -20,249 -20,561 -29,190 -18,761 -6,873 -2,541 -2,489 7,886 8,282 7,885 -26,271 -143 -386 -2,714
経常(税引前)利益率(%) -11.8 39.6 12.1 3.3 -10.8 -30.2 -27.8 -18.8 -38.6 -50.2 -60.5 -91.2 -10.3 -54.7 -53.6 -69.4 -37.4 -11.2 -3.8 -3.4 9.1 9.7 9.1 -29.9 -0.2 -0.5 -3.1
法人税等合計 0 0 - 0 - - - - 5 0 -8,725 134 -1,957 0 57 14 16 32 39 45 -1,034 6,013 -1,705 -423 -4,700 115 -382
実効税率(%) - - - - - -21.6 1.6 3286.7 -29.8 14.1
純利益 -1,270 5,849 2,055 570 -1,376 -4,589 -4,889 -4,280 -8,791 -11,791 -6,430 -24,623 -1,648 -20,249 -20,618 -29,204 -18,777 -6,905 -2,580 -2,534 8,920 2,269 9,590 -25,848 4,523 -501 -2,332
純利益率(%) 11.1 -29.4 5.2 -0.6 -2.7
一株あたり利益 - 0.43 0.12 0.03 -0.08 -0.23 -0.23 -0.17 -0.35 -0.47 -0.25 -0.97 -0.06 -0.77 -0.79 -1.1 -0.7 -0.26 -0.09 -0.09 0.32 0.08 0.35 -0.9 0.16 -0.02 -0.07
希薄化後一株あたり利益 - 0.05 0.11 0.03 -0.08 -0.23 -0.23 -0.17 -0.35 -0.47 -0.25 -0.97 -0.06 -0.77 -0.79 -1.1 -0.7 -0.26 -0.09 -0.09 0.31 0.08 0.32 -0.9 0.15 -0.02 -0.07
EBITDA - - - - - - - - - 9,818 1,836 -837 -2,988 -50
EBITDAマージン(%) - - - - - - - - - 11.4 2.1 -1.0 -3.6 -0.1